We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zimmer Biomet Holdings, Inc. (ZBH - Free Report) , a leading player in global musculoskeletal healthcare, recently announced the launch of Vanguard Individualized Design (ID), an advanced total knee arthroplasty (TKA) system. This latest design enables the implant to be a personalized fit which simplifies soft tissue preservation and balance.
Traditional total knee implants had a one-piece bearing of polyethylene placed between the metal portions. Vanguard ID is the only TKA system to include two individual polyethylene bearings with different articulations on the medial and lateral sides.
We note that Vanguard ID differs from its earlier versions of knee replacement products as well. The original Vanguard Knee system introduced in 2003 allowed personalization in knee replacement by offering a wide range of available sizes.
Management at Zimmer Biomet feels that Vanguard ID will transform the total knee replacement process. While simplifying the surgical process of knee implants, this system will help surgeons to achieve higher patient satisfaction.
As per a Medgadget report, the global knee implant market is forecasted to reach a worth of $15 billion in 2018, at a CAGR of 8.64% during 2011–2018. The knee implants market is benefitting from the rise in the rate of age-related diseases like osteoporosis, arthritis, diabetes, obesity, ageing population and injuries related to sports. Accordingly, we expect a huge uptake of the latest Vanguard product.
Notably, Zimmer Biomet has exhibited positive numbers in its knee implant portfolio in the recently concluded second quarter. It has recorded a 5% sales growth in the knee category. The company has a constant urge to develop quality knee-replacement solutions so that it can capture a larger share of the growing knee arthroplasty market.
Zacks Rank & Key Picks
Zimmer Biomet currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical product sector are GW Pharmaceuticals plc , NuVasive, Inc. and Quidel Corp. (QDEL - Free Report) . All these stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Zimmer Biomet Introduces Vanguard Individualized Design
Zimmer Biomet Holdings, Inc. (ZBH - Free Report) , a leading player in global musculoskeletal healthcare, recently announced the launch of Vanguard Individualized Design (ID), an advanced total knee arthroplasty (TKA) system. This latest design enables the implant to be a personalized fit which simplifies soft tissue preservation and balance.
Traditional total knee implants had a one-piece bearing of polyethylene placed between the metal portions. Vanguard ID is the only TKA system to include two individual polyethylene bearings with different articulations on the medial and lateral sides.
We note that Vanguard ID differs from its earlier versions of knee replacement products as well. The original Vanguard Knee system introduced in 2003 allowed personalization in knee replacement by offering a wide range of available sizes.
ZIMMER BIOMET Price
ZIMMER BIOMET Price | ZIMMER BIOMET Quote
Management at Zimmer Biomet feels that Vanguard ID will transform the total knee replacement process. While simplifying the surgical process of knee implants, this system will help surgeons to achieve higher patient satisfaction.
As per a Medgadget report, the global knee implant market is forecasted to reach a worth of $15 billion in 2018, at a CAGR of 8.64% during 2011–2018. The knee implants market is benefitting from the rise in the rate of age-related diseases like osteoporosis, arthritis, diabetes, obesity, ageing population and injuries related to sports. Accordingly, we expect a huge uptake of the latest Vanguard product.
Notably, Zimmer Biomet has exhibited positive numbers in its knee implant portfolio in the recently concluded second quarter. It has recorded a 5% sales growth in the knee category. The company has a constant urge to develop quality knee-replacement solutions so that it can capture a larger share of the growing knee arthroplasty market.
Zacks Rank & Key Picks
Zimmer Biomet currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical product sector are GW Pharmaceuticals plc , NuVasive, Inc. and Quidel Corp. (QDEL - Free Report) . All these stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>